No earnings forecast score is currently available for Prophase Labs Inc. The Healthcare Providers & Services industry's average is 7.54. The average price target is 16.00, with a high of 16.00 and a low of 16.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Prophase Labs Inc's price target?
Analysts forecast that Prophase Labs Inc's price target is USD 16.00, with the highest forecast at USD 16.00 and the lowest forecast at USD 16.00.